Silvia Panigone

Ikonisys, Inc. designs and manufactures medical diagnostic products for the diagnosis of cancers. Its products include Ikoniscope Robotic Microscope that provides automated slide handling, slide scanning, real-time image capture and analysis, eliminates various factors that cause human error in testing, oncoFISH bladder that allows scanning and analysis of cells recovered from a voided urine sample. The company was founded by Pramod K. Srivastava, Petros Tsipouras, Gamil G. de Chadarevian, Michael W. Kilpatrick and Triantafyllos Tafas in 1999 and is headquartered in New Haven, CT.

Teoresi SpA provides technological services. The company is headquartered in Turin, Italy.

Outcome Capital LLC is a life sciences and healthcare advisory and investment banking firm that specializes in providing innovative companies with a value-added, market-aligned approach to mergers & acquisitions, partnering, and corporate finance. The firm was founded by Jonathan R. Wallace and is based in Boston, MA, with subsidiaries in the United States. The firm's multi-disciplinary team of industry experts draws from their broad relationships and a wide range of scientific, operational, strategic, and transactional expertise across the value chain to assist management teams and their boards in navigating both financial and corporate markets and implementing the best path for success.

I-Bankers Direct LLC operates an online portal where accredited investors and companies can efficiently connect. It helps accredited investors to browse investment opportunities in growth companies efficiently. The company was founded in December 2012 and is headquartered in New York, NY.

I-Bankers Securities, Inc. is a broker/dealer headquartered in Santa Monica, California that was founded in 1996. I-Bankers provides a full array of trading and execution services for their clients. Their focus is to provide small-cap issuers access the capital markets while they enable institutional investors to gain access to choice small-cap investments. Their clients include institutions, private bankers and high-net worth individuals. The firm also manages, underwrites and distributes “blank check” or “SPAC” offerings.

AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC.